Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the ...
(UPDATED) A hastily convened collaboration between physicians, pharmacists, and industry experts has pulled together guidance for hospitals and clinicians navigating the US dobutamine shortage that ...
A head-to-head comparison of inotropes in the setting of cardiogenic shock revealed no clear victor, with milrinone and dobutamine providing similar outcomes in the randomized DOREMI trial. A ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Dobutamine Hydrochloride Injection contains the active ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results